MoneyWorks4Me

Norris Medicines submits standalone un-audited financial results

06 Feb 2020 Evaluate

Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Norris Medicines has informed about submission of Standalone Un-audited Financial Results of the Company for the Quarter and nine month ended on 31st December, 2019; and Limited Review Report by Statutory Auditors on Standalone Un-audited Financial Results for the quarter and nine month ended on 31st December, 2019.

The above information is a part of company's filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..